ClinicalTrials.Veeva

Menu

System Accuracy of BGM GL60

I

Institut fur Diabetes Karlsburg GmbH

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Diagnostic Test: Glucometer Test

Study type

Interventional

Funder types

Other

Identifiers

NCT06037486
2022_002

Details and patient eligibility

About

This study assesses the system accuracy a blood glucose monitoring systems pursuant to ISO 15197

Full description

This study assesses the system accuracy ofthe blood glucose monitoring systems for personal use GL60 as outlined in DIN EN ISO 15197:2015.

Enrollment

101 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female patients with hypo-, eu- or hyperglycaemia
  • The written informed consent had to be signed
  • The volunteers must be older than 18 years
  • The volunteers have legal capacity and are able to understand meaning, nature and possible consequences of the procedures involved

Exclusion criteria

  • Pregnancy or lactation
  • Acute or chronic diseases with the risk of aggravation by the measure
  • A current constitution that does not allow participating in the study
  • Participation in another study or activity with the blood glucose measuring system evaluated in the present study
  • Application of substances listed in Appendix A of DIN EN ISO 15197:2015

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

101 participants in 1 patient group

Subject glucometer measurement
Experimental group
Treatment:
Diagnostic Test: Glucometer Test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems